Recursion Pharmaceuticals Inc is trading 11.5% up today at $3.87 in what appears to be a technical rebound following several days of share price weakness and a recent downtrend.
- Market commentary characterizes the move as a recovery bounce on strong early-session buying rather than a reaction to fresh fundamental news.
- There are no new company-specific headlines, earnings, FDA decisions, or major analyst calls reported for the June 4, 2026 session.